CohBar

United States
New Lisbon, Wisconsin, United States
4153818980 ★

Company profile

CohBar company profile

CohBar is a clinical-stage biotechnology company that focuses on the research and development of mitochondria based therapeutics. It has developed proprietary mitochondria based therapeutic (MBT) platform technology, using cell-based assays and animal models of disease, to rapidly identify naturally occurring MDPs with promising biological activity. The company was founded in 2007 and is headquartered in Menlo Park, California.

Business identity

Contact email
[email protected]
Phone number
4153818980
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$0+
Founded
2007-01-01

Headquarters

Headquarters
New Lisbon, Wisconsin, United States
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
5
Total equity funding
$35.6M
Last funding
Post Ipo Equity / $15M / 2021-10-28
Last equity funding
Post Ipo Equity / $15M
Founders
5
Articles
39
Exited on
2017-12-15

Founders and investors

Founders

David SinclairJohn AmatrudaLaura J. CobbNir BarzilaiPinchas Cohen

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.